血管内介入减少胃静脉曲张再出血:个体患者数据荟萃分析
本研究通过聚合数据荟萃分析和个体患者数据倾向评分匹配荟萃分析,比较BRTO、TIPS与内镜氰基丙烯酸酯注射(ECI)对肝硬化胃静脉曲张出血二级预防的效果。结果显示BRTO和TIPS均显著降低全因再出血风险,但无生存获益;BRTO增加腹水风险,TIPS增加肝性脑病风险。
要点
- BRTO和TIPS均显著降低胃静脉曲张再出血风险,优于ECI。
- BRTO增加新发或原有腹水恶化风险,TIPS增加肝性脑病风险。
- 再出血减少在Child-Pugh B级肝硬化患者中最明显。
核心结论
- 对于肝硬化胃静脉曲张出血患者,血管内介入(BRTO和TIPS)在减少全因再出血方面优于ECI,但无生存获益。
研究设计与样本
- 聚合数据荟萃分析纳入15项研究(11项观察性研究和4项RCT),共1240例患者(ECI 377例,BRTO 575例,TIPS 288例)。
- 个体患者数据荟萃分析从RCT中收集数据,在倾向评分匹配队列中进行。
主要发现
- 再出血减少的获益在Child-Pugh B级肝硬化患者中最明显。
临床怎么用
- 对于肝硬化胃静脉曲张出血的二级预防,可考虑BRTO或TIPS以降低再出血风险,但需权衡腹水或肝性脑病风险。
局限性
- 长期结局数据有限。
- reported trial outcomes不一致。
- 结果存在显著异质性,尤其是关于TIPS。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: There is no consensus on the optimal modality of secondary prophylaxis for gastric variceal (GV) bleeding in patients with cirrhosis. METHODS: Observational studies and randomized controlled trials (RCTs) comparing endovascular interventions-balloon-occluded retrograde transvenous obliteration (BRTO) and transjugular intrahepatic portosystemic shunt (TIPS)-with endoscopic cyanoacrylate injection (ECI) were considered for the aggregate data meta-analysis. Individual patient data were collected from RCTs to perform an individual patient data meta-analysis in a propensity score-matched cohort. The primary outcome was comparison of the rates of all-cause rebleeding between ECI, BRTO, and TIPS. Secondary outcomes included overall survival, ascites, and hepatic encephalopathy. RESULTS: Fifteen studies (11 observational and 4 RCTs) comprising 1240 patients (ECI: 377, BRTO: 575, and TIPS: 288) were included in the aggregate data meta-analysis. In the individual patient data meta-analysis, both BRTO (subdistribution hazard ratio [sHR], 0.15; 95% confidence interval [CI], 0.05-0.43; P = .004) and TIPS (sHR, 0.49; 95% CI, 0.27-0.89; P = .019) significantly reduced all-cause rebleeding compared with ECI, without survival benefit. BRTO was associated with a higher risk of new-onset or worsening of pre-existing ascites (sHR, 3.54; 95% CI, 1.31-9.55; P = .013); TIPS increased the risk of hepatic encephalopathy (sHR, 8.84; 95% CI, 2.0-39.11; P = .004) compared with ECI. Benefit in rebleeding reduction was most pronounced among patients with Child-Pugh class B cirrhosis. The analysis revealed limited long-term outcome data, inconsistencies in reported trial outcomes, and significant heterogeneity in results, particularly regarding TIPS. CONCLUSIONS: Endovascular interventions (BRTO and TIPS) are superior to ECI for reducing all-cause rebleeding in patients with cirrhosis and gastric variceal hemorrhage. Larger studies with standardized end points and long-term outcomes are needed to clarify survival benefit and optimize treatment selection.
引用
- Biswas S, Aggarwal A, Lo GH, et al. Endovascular Interventions Reduce Rebleeding in Patients With Gastric Varices: An Individual Patient Data Meta-Analysis. Clin Gastroenterol Hepatol. 2026. PMID: 41539349. doi:10.1016/j.cgh.2026.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。